8636 results
-
List item
Human medicine European public assessment report (EPAR): Intrarosa (updated)
Prasterone, Menopause
Date of authorisation: 08/01/2018,
, Revision: 2, Authorised
-
List item
Human medicine European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) (updated)
dinutuximab beta, Neuroblastoma
Date of authorisation: 08/05/2017,, 
, 
, Revision: 5, Authorised
-
List item
Human medicine European public assessment report (EPAR): Zeffix (updated)
lamivudine, Hepatitis B, Chronic
Date of authorisation: 28/07/1999, Revision: 23, Authorised -
List item
Human medicine European public assessment report (EPAR): Hyrimoz (updated)
adalimumab, Hidradenitis Suppurativa, Crohn Disease, Arthritis, Juvenile Rheumatoid, Uveitis, Arthritis, Rheumatoid, Colitis, Ulcerative, Spondylitis, Ankylosing, Skin Diseases, Papulosquamous, Arthritis, Psoriatic
Date of authorisation: 26/07/2018,, 
, Revision: 2, Authorised
-
List item
Human medicine European public assessment report (EPAR): Orgalutran (updated)
ganirelix, Reproductive Techniques, Assisted, Ovulation Induction
Date of authorisation: 16/05/2000, Revision: 18, Authorised -
List item
Human medicine European public assessment report (EPAR): Temozolomide Accord (updated)
temozolomide, Glioma, Glioblastoma
Date of authorisation: 15/03/2010,
, Revision: 17, Authorised
-
List item
Human medicine European public assessment report (EPAR): Hefiya (updated)
adalimumab, Hidradenitis Suppurativa, Spondylitis, Ankylosing, Psoriasis, Arthritis, Juvenile Rheumatoid, Uveitis
Date of authorisation: 26/07/2018,, , Revision: 2, Authorised
-
List item
Human medicine European public assessment report (EPAR): Axumin (updated)
Fluciclovine (18F), Prostatic Neoplasms, Radionuclide Imaging
Date of authorisation: 21/05/2017,, Revision: 6, Authorised
-
List item
Human medicine European public assessment report (EPAR): Bortezomib Hospira (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016,, Revision: 6, Authorised
-
List item
Human medicine European public assessment report (EPAR): Remicade (updated)
infliximab, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Crohn Disease, Arthritis, Psoriatic, Colitis, Ulcerative
Date of authorisation: 13/08/1999, Revision: 53, Authorised -
List item
Human medicine European public assessment report (EPAR): Cinqaero (updated)
Reslizumab, Asthma
Date of authorisation: 15/08/2016,, Revision: 7, Authorised
-
List item
Human medicine European public assessment report (EPAR): Orkambi (updated)
Lumacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 18/11/2015,, Revision: 17, Authorised
-
List item
Human medicine European public assessment report (EPAR): Invirase (updated)
saquinavir, HIV Infections
Date of authorisation: 03/10/1996, Revision: 46, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Longrange (updated)
eprinomectin, Cattle Refused -
List item
Human medicine European public assessment report (EPAR): Silapo (updated)
epoetin zeta, Anemia, Blood Transfusion, Autologous, Cancer, Kidney Failure, Chronic
Date of authorisation: 18/12/2007,, Revision: 14, Authorised
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Accord (updated)
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 15/11/2015,, Revision: 7, Authorised
-
List item
Human medicine European public assessment report (EPAR): Bortezomib Sun (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016,, Revision: 6, Authorised
-
List item
Human medicine European public assessment report (EPAR): Apidra (updated)
insulin glulisine, Diabetes Mellitus
Date of authorisation: 27/09/2004, Revision: 27, Authorised -
List item
Human medicine European public assessment report (EPAR): Cystadrops (updated)
mercaptamine hydrochloride, Cystinosis
Date of authorisation: 18/01/2017,, Revision: 4, Authorised
-
List item
Human medicine European public assessment report (EPAR): Jalra (updated)
vildagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 18/11/2008, Revision: 18, Authorised -
List item
Human medicine European public assessment report (EPAR): Trimbow (updated)
Beclometasone dipropionate, formoterol fumarate dihydrate, Glycopyrronium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 17/07/2017, Revision: 1, Authorised -
List item
Human medicine European public assessment report (EPAR): Tenofovir disoproxil Zentiva (updated)
tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 15/09/2016,, Revision: 4, Authorised
-
List item
Human medicine European public assessment report (EPAR): Xolair (updated)
omalizumab, Asthma, Urticaria
Date of authorisation: 25/10/2005, Revision: 35, Authorised -
List item
Human medicine European public assessment report (EPAR): Palonosetron Accord (updated)
Palonosetron, Vomiting, Nausea, Cancer
Date of authorisation: 26/05/2016,, Revision: 2, Authorised
-
List item
Veterinary medicine European public assessment report (EPAR): Reconcile (updated)
fluoxetine, Dogs
Date of authorisation: 08/07/2008, Revision: 10, Authorised